109451 ⎘
Coculture with; Conditioned medium produced by blood or immune system cells Dendritic cells
SYSTEMS AND METHODS FOR CELL CULTURING
#2SYSTEMS AND METHODS FOR CELL CULTURING
#3METHOD FOR PROLIFERATING CAR-T CELLS, AND LIPID PARTICLES AND KIT FOR USE IN THE METHOD
#4COMPOSITIONS AND METHODS FOR PRODUCING ANTIBODY-GENERATING IMMUNE ORGANOIDS
#5T-CELL EXPANSION METHOD AND USES
#6CELL SYSTEM AND APPLICATION THEREOF, AND METHOD FOR ACTIVATING BROAD-SPECTRUM CANCER CELL-SPECIFIC T CELL
#7Method of Use for Benzofuran Compounds
#8SELECTIVE TOLERIZATION - METHODS OF SELECTIVELY GENERATING TOLEROGENIC DENDRITIC CELLS
#9SYSTEMS AND METHODS FOR CELL CULTURING
#10METHODS FOR PRODUCTION OF TISSUE RESIDENT MEMORY-LIKE T CELLS AND USE THEREOF
#11VIRUS-SPECIFIC T CELLS, METHODS OF THEIR PREPARATION AND USE THEREOF
#12SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREOF
#13T-CELL EXPANSION METHOD AND USES
#14T CELL MANUFACTURING COMPOSITIONS AND METHODS
#15Method to Treat Cancer with Engineered T-Cells
#16METHODS FOR SELECTIVELY REDUCING IMMUNOGENICITY IN A TRANSPLANT
#17QUALITY CONTROL METHODS FOR AUTOMATED CELL PROCESSING
#18SYSTEMS AND METHODS FOR CELL CULTURING
#19METHODS FOR EX VIVO ENRICHMENT AND EXPANSION OF TUMOR REACTIVE T CELLS AND RELATED COMPOSITIONS THEREOF
#20SYSTEMS AND METHODS FOR CELL CULTURING
#21SYSTEMS AND METHODS FOR CELL CULTURING
#22NK CELLS EXHIBITING AN ADAPTIVE PHENOTYPE AND METHODS FOR PREPARING AND FOR USING
#23A METHOD FOR PRODUCING ANTIGEN-SPECIFIC T CELLS
#24IN-SITU CRYO-IMMUNE ENGINEERING FOR CANCER IMMUNOTHERAPY
#25METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES
#26METHOD FOR LARGE-SCALE PRODUCTION OF HUMAN ALLOSPECIFIC INDUCED-REGULATORY T CELLS WITH FUNCTIONAL STABILITY IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#27METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#28NOVEL ESR1 DERIVED PEPTIDES AND USES THEREOF FOR NEOANTIGEN THERAPY
#29METHOD FOR T-CELL EXPANSION AND RELATED MEDICAL APPLICATIONS
#30MODULATING BHLHE40 IN THE DIFFERENTIATION OF TYPE 1 REGULATORY T CELLS AND CONTROLLING T CELL EXHAUSTION
#31METHOD FOR GENERATING HUMAN DENDRITIC CELLS FOR IMMUNOTHERAPY
#32KSHV ONCOPROTEIN ANTIGENS AND EPITOPES FOR EXPANDING ANTIGEN-SPECIFIC T CELLS
#33DENDRITIC CELL ASSAY FOR INNATE IMMUNOGENICITY TO GENE THERAPY AGENTS
#34USE OF AN IRAK4 MODULATOR FOR GENE THERAPY
#35RAS NEOANTIGENS AND USES THEREOF
#36ANTI-VIRAL CENTRAL MEMORY CD8+ VETO CELLS IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION
#37VETO CELLS GENERATED FROM MEMORY T CELLS
#38T CELL MANUFACTURING COMPOSITIONS AND METHODS
#39PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION
#40ELECTROPORATION-BASED PLATFORM FOR GENERATION OF TUMOR-ACTIVATED T CELLS
#41MEMBRANE-BOUND IL-15, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF
#42PROGRAMMING OF REGULATORY T CELLS BY EXTRACELLULAR VESICLES
#43EX VIVO EXPANSION OF REGULATORY T CELLS FOR SUPPRESSION OF GRAFT VERSUS HOST DISEASE
#44IMMUNOTHERAPY
#45GENERATION OF TUMOR IMMUNITY USING ASTROCYTES AND ASTROCYTE-DENDRITIC CELL COMBINATIONS
#46T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#47T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#48PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE
#49T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#50COMPOSITIONS AND METHODS OF GENERATING AN IMMUNE RESPONSE
#51T CELL RECEPTORS WITH VGLL1 SPECIFICITY AND USES THEREOF
#52VIRAL DETECTION ASSAY
#53SYSTEMS AND METHODS FOR CELL CULTURING
#54METHOD OF PRODUCING TUMOR-REACTIVE T CELL COMPOSITION USING MODULATORY AGENTS
#55Restimulation of cryopreserved tumor infiltrating lymphocytes
#56Systems and methods for cell culturing
#57Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
#58METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#59IMPROVED PROCESS FOR CULTURING TUMOR-INFILTRATING LYMPHOCYTES FOR THERAPEUTIC USE
#60HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOF
#61METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#62Restimulation of cryopreserved tumor infiltrating lymphocytes
#63Restimulation of cryopreserved tumor infiltrating lymphocytes
#64Restimulation of cryopreserved tumor infiltrating lymphocytes
#65IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER
#66RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
#67Restimulation of cryopreserved tumor infiltrating lymphocytes
#68HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE THEREOF
#69BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS
#70INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF
#71METHODS FOR PRODUCTION OF CAR-NK CELLS AND USE THEREOF
#72EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF CANCER
#73Systems and methods for cell culturing
#74MULTIPLE ANTIGEN SPECIFIC CELL THERAPY METHODS
#75Systems and methods for cell culturing
#76Methods of cancer treatment using activated t cells
#77METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
#78THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES
#79EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS
#80METHOD FOR PREPARATION OF CANCER/TESTIS ANTIGEN-SPECIFIC T-CELLS
#81METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT CANCERS AND COMPOSITIONS THEREOF
#82Restimulation of cryopreserved tumor infiltrating lymphocytes
#83METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#84Methods of cancer treatment using tumor antigen-specific T cells
#85EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THERAPEUTIC USES THEREOF
#86Restimulation of cryopreserved tumor infiltrating lymphocytes
#87VIRUS SPECIFIC CYTOKINE-INDUCED KILLER CELLS
#88Restimulation of cryopreserved tumor infiltrating lymphocytes
#89Restimulation of cryopreserved tumor infiltrating lymphocytes
#90ISOLATED MHC-DERIVED HUMAN PEPTIDES AND USES THEREOF FOR STIMULATING AND ACTIVATING THE SUPPRESSIVE FUNCTION OF CD8+CD45RCLOW TREGS
#91Restimulation of cryopreserved tumor infiltrating lymphocytes
#92Restimulation of cryopreserved tumor infiltrating lymphocytes
#93Restimulation of cryopreserved tumor infiltrating lymphocytes
#94Restimulation of cryopreserved tumor infiltrating lymphocytes
#95Restimulation of cryopreserved tumor infiltrating lymphocytes
#96Restimulation of cryopreserved tumor infiltrating lymphocytes
#97GENERATING HPV ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#98METHOD FOR AMPLIFYING ANTIGEN-SPECIFIC REGULATORY T CELLS IN VITRO
#99Structural and functional characteristics of yeast-derived polysaccharide inducing Treg cell
#100Methods for production of tissue resident memory-like T cells and use thereof
#101TREATMENT METHODS
#102METHODS OF MAKING NATURAL KILLER CELLS AND USES THEREOF
#103NK cells exhibiting an adaptive phenotype and methods for preparing and for using
#104GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#105PRODUCTION OF ENGINEERED DENDRITIC CELLS AND USES THEREOF
#106Methods of cancer treatment using activated T cells
#107Restimulation of cryopreserved tumor infiltrating lymphocytes
#108Restimulation of cryopreserved tumor infiltrating lymphocytes
#109Restimulation of cryopreserved tumor infiltrating lymphocytes
#110Veto cells generated from memory T cells
#111Methods of obtaining tumor-specific T cell receptors
#112Generating HPV antigen-specific cells from a naive T cell population
#113COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME
#114Generating HPV antigen-specific cells from a naive T cell population
#115Methods of cancer treatment using tumor antigen-specific T cells
#116Quality control methods for automated cell processing
#117METHOD FOR LARGE-SCALE PRODUCTION OF HUMAN ALLOSPECIFIC INDUCED-REGULATORY T CELLS WITH FUNCTIONAL STABILITY IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#118Systems and methods for cell culturing
#119Systems and methods for cell culturing
#120SYSTEMS AND METHODS FOR CELL CULTURING
#121Systems and methods for cell culturing
#122Systems and methods for cell culturing
#123Systems and methods for cell culturing
#124Methods of cancer treatment using activated T cells
#125MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS
#126T-CELL EXHAUSTION, METHODS & COMPOSITIONS RELATING THERETO
#127strain and strain-derived polysaccharide
#128Multiple antigen specific cell therapy methods
#129Method for activating T cells for cancer treatment
#130T-reg cell expansion
#131METHOD FOR PREPARING ANTIGEN-SPECIFIC REGULATORY T CELLS
#132Restimulation of cryopreserved tumor infiltrating lymphocytes
#133Method to treat cancer with engineered T-cells
#134Method for activating T cells for cancer treatment
#135TREATMENT OF LIVER FAILURE WITH ACTIVATED T REGULATORY CELLS
#136COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME
#137T-CELL EXPANSION METHOD AND USES
#138Indole regulation of antigen presenting cells
#139Pharmaceutical composition and methods comprising immune cells and ponatinib
#140Three-dimensional printed organs, devices, and matrices
#141Methods of culturing t cells and uses of same
#142HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
#143Three-dimensional in vitro lung model, process for preparing said model, and its use for determining and /or predicting the sensitizing effects of inhalable products
#144TARGET PEPTIDES FOR CANCER THERAPY AND DIAGNOSTICS
#145Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
#146Method for inducing amplification of type I NKT cells in vitro
#147Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#148Veto cells generated from memory T cells
#149Process of expanding T cells
#150Induced dendritic cells and uses thereof
#151Generation of HPV-specific T-cells
#152In vitro neonatal biomimetic (nMIMIC) model and methods of using same
#153TRANSFECTION OF DENDRITIC CELLS AND METHODS THEREFOR
#154Ex vivo generation of γδ Foxp3regulatory T cells and therapeutic uses thereof
#155Ex vivo generation of MHCII restricted CD4FOXP3regulatory T cells and therapeutic uses thereof
#156Method to treat cancer with engineered T-cells
#157Methods for printing organs and organoids
#158METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF
#159Mode of inducing renal transplant rejection on animals and its manufacturing approach
#160Generating HPV antigen-specific cells from a naive T cell population
#161NK cells exhibiting an adaptive phenotype and methods for preparing and for using
#162Generation of HPV-specific T-cells
#163Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#164Method for generating human dendritic cells for immunotherapy
#165T-REG cell expansion
#166COMPOSITIONS AND METHODS OF TREATING CANCER
#167Methods of cancer treatment using activated T cells
#168ANTI-TUMOR VACCINE DERIVED FROM NORMAL CELLS
#169Method for activating and expanding NKT-like cells in vitro
#170PRODUCTION METHOD FOR PLURIPOTENT STEM CELLS HAVING ANTIGEN-SPECIFIC T CELL RECEPTOR GENE
#171POPULATION OF IMMUNOREGULATORY T CELLS SPECIFIC FOR AN IRRELEVANT ANTIGEN AND USES THEREOF FOR PREVENTING OR TREATING IMMUNE DISEASES
#172TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME
#173Isolated donor MHC-derived peptide and uses thereof
#174Method for priming of T cells
#175Isolated donor MHC-derived peptide and uses thereof
#176WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
#177Formulation and method for preparing specific T cell, and method for preparing the formulation
#178DENDRITIC CELL TUMOR VACCINE AND METHOD FOR PREPARING THE SAME
#179Tolerogenic dendritic cells, method for their production and uses therof
#180IN VITRO SYSTEM FOR GENERATION OF ANTIGEN-SPECIFIC IMMUNE RESPONSES
#181Induced dendritic cells and uses thereof
#182Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populations
#183Method for inducing fusion of dendritic cell with tumour cell
#184ARTIFICIAL SKIN TISSUE, ARTIFICIAL SKIN MODEL AND MANUFACTURING METHOD THEREFOR
#185COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES MEDIATED BY ANTIGEN-PRESENTING CELLS
#186METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC REGULATORY T CELLS
#187Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#188Process of expanding T cells
#189Artificial immune system: methods of use
#190Methods for testing an immune response using cultures of T cells, B cells, dendritic cells and follicular dendritic cells
#191Method for priming of T cells
#192IN VITRO UROGENITAL CO-CULTURE MODELS
#193Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
#194Methods for testing an immune response using cultures of T cells, B cells and dendritic cells
#195Methods for assaying responses to vaccines
#196Methods of evaluating an immune response to an antigen
#197Artificial immune system: methods for making and use
#198METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
#199METHOD FOR PRODUCING LANGERHANS CELLS OR INTERSTITIAL DENDRITIC CELLS OR BOTH FROM CD14+ MONOCYTES
#200In vitro germinal centers
#201Methods for antibody production
#202Method for determining the immunogenicity of an antigen
#203Anti-tumour vaccine derived from normal cells
#204Tolerogenic dendritic cells, method for their production and uses therof
#205Method for determining the immunogenicity of an antigen
#206Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes
#207Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
#208Three dimensional vaginal tissue model containing immune cells
#209In vitro germinal centers
#210Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
#211Artificial lymphoid tissue equivalent
#212In vitro mucosal tissue equivalent
#213Automatable artificial immune system (AIS)
#214Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#215Artificial immune system: methods for making and use